Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG) : policy review

Immune checkpoint inhibitors (ICIs) have substantially advanced the treatment landscape for a wide variety of malignancies. Older adults represent a large and rapidly growing demographic, among whom ICIs are widely prescribed. Management of ICI-associated toxicity among older adults, particularly in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mac Eochagain, Colm (VerfasserIn) , Neuendorff, Nina Rosa (VerfasserIn) , Gente, Karolina (VerfasserIn) , Leipe, Jan (VerfasserIn) , Verhaert, Marthe (VerfasserIn) , Sam, Christine (VerfasserIn) , de Glas, Nienke (VerfasserIn) , Kadambi, Sindhuja (VerfasserIn) , Canin, Beverly (VerfasserIn) , Gomes, Fabio (VerfasserIn) , Decoster, Lore (VerfasserIn) , Korc-Grodzicki, Beatriz (VerfasserIn) , Rostoft, Siri (VerfasserIn) , Battisti, Nicolò Matteo Luca (VerfasserIn) , Wildiers, Hans (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 2025
In: The lancet. Oncology
Year: 2025, Jahrgang: 26, Heft: 2, Pages: 90-102
ISSN:1474-5488
DOI:10.1016/S1470-2045(24)00404-2
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S1470-2045(24)00404-2
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1470204524004042
Volltext
Verfasserangaben:Colm Mac Eochagain, Nina Rosa Neuendorff, Karolina Gente, Jan Leipe, Marthe Verhaert, Christine Sam, Nienke de Glas, Sindhuja Kadambi, Beverly Canin, Fabio Gomes, Lore Decoster, Beatriz Korc-Grodzicki, Siri Rostoft, Nicolò Matteo Luca Battisti, Hans Wildiers

MARC

LEADER 00000naa a2200000 c 4500
001 1930485069
003 DE-627
005 20250715103100.0
007 cr uuu---uuuuu
008 250715s2025 xx |||||o 00| ||eng c
024 7 |a 10.1016/S1470-2045(24)00404-2  |2 doi 
035 |a (DE-627)1930485069 
035 |a (DE-599)KXP1930485069 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Mac Eochagain, Colm  |e VerfasserIn  |0 (DE-588)1371547793  |0 (DE-627)1930485964  |4 aut 
245 1 0 |a Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer  |b recommendations from the International Society of Geriatric Oncology (SIOG) : policy review  |c Colm Mac Eochagain, Nina Rosa Neuendorff, Karolina Gente, Jan Leipe, Marthe Verhaert, Christine Sam, Nienke de Glas, Sindhuja Kadambi, Beverly Canin, Fabio Gomes, Lore Decoster, Beatriz Korc-Grodzicki, Siri Rostoft, Nicolò Matteo Luca Battisti, Hans Wildiers 
264 1 |c February 2025 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.07.2025 
500 |a Online verfügbar: 3. Februar 2025, Artikelversion: 3. Februar 2025 
520 |a Immune checkpoint inhibitors (ICIs) have substantially advanced the treatment landscape for a wide variety of malignancies. Older adults represent a large and rapidly growing demographic, among whom ICIs are widely prescribed. Management of ICI-associated toxicity among older adults, particularly in the presence of frailty and comorbidity, poses unique challenges. In this Policy Review, developed by the International Society of Geriatric Oncology (SIOG), we offer an evidence-based framework for health-care providers, caregivers, and policy makers for treating older adults with ICIs, focusing on unique considerations for this population that are not adequately addressed by existing guidelines, and expanding them to encompass geriatric oncology principles. 
700 1 |a Neuendorff, Nina Rosa  |e VerfasserIn  |4 aut 
700 1 |a Gente, Karolina  |d 1986-  |e VerfasserIn  |0 (DE-588)1066617481  |0 (DE-627)817734120  |0 (DE-576)426070216  |4 aut 
700 1 |a Leipe, Jan  |d 1976-  |e VerfasserIn  |0 (DE-588)131797824  |0 (DE-627)51426280X  |0 (DE-576)298758563  |4 aut 
700 1 |a Verhaert, Marthe  |e VerfasserIn  |4 aut 
700 1 |a Sam, Christine  |e VerfasserIn  |4 aut 
700 1 |a de Glas, Nienke  |e VerfasserIn  |4 aut 
700 1 |a Kadambi, Sindhuja  |e VerfasserIn  |4 aut 
700 1 |a Canin, Beverly  |e VerfasserIn  |4 aut 
700 1 |a Gomes, Fabio  |e VerfasserIn  |4 aut 
700 1 |a Decoster, Lore  |e VerfasserIn  |4 aut 
700 1 |a Korc-Grodzicki, Beatriz  |e VerfasserIn  |4 aut 
700 1 |a Rostoft, Siri  |e VerfasserIn  |4 aut 
700 1 |a Battisti, Nicolò Matteo Luca  |e VerfasserIn  |4 aut 
700 1 |a Wildiers, Hans  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t The lancet. Oncology  |d London : The Lancet Publ. Group, 2000  |g (26)2025, 2, Seite e90-e102  |h Online-Ressource  |w (DE-627)325349770  |w (DE-600)2035574-9  |w (DE-576)100517544  |x 1474-5488  |7 nnas  |a Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer recommendations from the International Society of Geriatric Oncology (SIOG) : policy review 
773 1 8 |g volume:26  |g year:2025  |g number:2  |g month:02  |g pages:90-102  |g extent:13  |a Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer recommendations from the International Society of Geriatric Oncology (SIOG) : policy review 
856 4 0 |u https://doi.org/10.1016/S1470-2045(24)00404-2  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1470204524004042  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250715 
993 |a Article 
994 |a 2025 
998 |g 131797824  |a Leipe, Jan  |m 131797824:Leipe, Jan  |d 60000  |d 61400  |e 60000PL131797824  |e 61400PL131797824  |k 0/60000/  |k 1/60000/61400/  |p 4 
999 |a KXP-PPN1930485069  |e 4746339295 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 15.07.2025","Online verfügbar: 3. Februar 2025, Artikelversion: 3. Februar 2025"],"person":[{"given":"Colm","role":"aut","display":"Mac Eochagain, Colm","family":"Mac Eochagain","roleDisplay":"VerfasserIn"},{"given":"Nina Rosa","role":"aut","display":"Neuendorff, Nina Rosa","family":"Neuendorff","roleDisplay":"VerfasserIn"},{"given":"Karolina","role":"aut","display":"Gente, Karolina","family":"Gente","roleDisplay":"VerfasserIn"},{"family":"Leipe","roleDisplay":"VerfasserIn","display":"Leipe, Jan","role":"aut","given":"Jan"},{"roleDisplay":"VerfasserIn","family":"Verhaert","display":"Verhaert, Marthe","role":"aut","given":"Marthe"},{"display":"Sam, Christine","role":"aut","given":"Christine","family":"Sam","roleDisplay":"VerfasserIn"},{"role":"aut","display":"de Glas, Nienke","given":"Nienke","family":"de Glas","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Kadambi, Sindhuja","given":"Sindhuja","roleDisplay":"VerfasserIn","family":"Kadambi"},{"roleDisplay":"VerfasserIn","family":"Canin","role":"aut","display":"Canin, Beverly","given":"Beverly"},{"family":"Gomes","roleDisplay":"VerfasserIn","role":"aut","display":"Gomes, Fabio","given":"Fabio"},{"family":"Decoster","roleDisplay":"VerfasserIn","given":"Lore","display":"Decoster, Lore","role":"aut"},{"given":"Beatriz","role":"aut","display":"Korc-Grodzicki, Beatriz","family":"Korc-Grodzicki","roleDisplay":"VerfasserIn"},{"family":"Rostoft","roleDisplay":"VerfasserIn","display":"Rostoft, Siri","role":"aut","given":"Siri"},{"roleDisplay":"VerfasserIn","family":"Battisti","given":"Nicolò Matteo Luca","display":"Battisti, Nicolò Matteo Luca","role":"aut"},{"family":"Wildiers","roleDisplay":"VerfasserIn","role":"aut","display":"Wildiers, Hans","given":"Hans"}],"physDesc":[{"extent":"13 S."}],"id":{"doi":["10.1016/S1470-2045(24)00404-2"],"eki":["1930485069"]},"relHost":[{"part":{"extent":"13","volume":"26","issue":"2","year":"2025","pages":"90-102","text":"(26)2025, 2, Seite e90-e102"},"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"pubHistory":["0.2000 -"],"recId":"325349770","disp":"Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer recommendations from the International Society of Geriatric Oncology (SIOG) : policy reviewThe lancet. Oncology","title":[{"title_sort":"lancet","title":"The lancet","partname":"Oncology"}],"origin":[{"publisher":"The Lancet Publ. Group","dateIssuedKey":"2000","dateIssuedDisp":"2000-","publisherPlace":"London"}],"titleAlt":[{"title":"The lancet <London> / Oncology"}],"id":{"zdb":["2035574-9"],"eki":["325349770"],"issn":["1474-5488"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 22.09.2021"]}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"February 2025"}],"title":[{"title_sort":"Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer","subtitle":"recommendations from the International Society of Geriatric Oncology (SIOG) : policy review","title":"Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer"}],"recId":"1930485069","type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"name":{"displayForm":["Colm Mac Eochagain, Nina Rosa Neuendorff, Karolina Gente, Jan Leipe, Marthe Verhaert, Christine Sam, Nienke de Glas, Sindhuja Kadambi, Beverly Canin, Fabio Gomes, Lore Decoster, Beatriz Korc-Grodzicki, Siri Rostoft, Nicolò Matteo Luca Battisti, Hans Wildiers"]}} 
SRT |a MACEOCHAGAMANAGEMENT2025